Economic portfolio
NIPPON INDIA PHARMA FUND
NIPPON Nippon India Mutual Fund Feb 2022 — Sep 2026 55 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 22.8 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
55 priced months, Feb 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
57.9% now, 58.4% in Sep 2025 · highest 74.1%, lowest 56.7%
Companies held
36 now, 37 in Sep 2025 · largest single holding 12.0% of equity
How long new positions last: of the 16 companies this fund started holding between Mar 2022 and Jul 2025, 81% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →
How it trades: leans toward adding to shares that fell over the previous six months (score -0.56 over 7 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life · 28 shared65.3%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 26 shared61.9%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 34 shared60.4%
- Bandhan BSE Healthcare Index FundBandhan · 34 shared60.4%
- EODWHFEdelweiss · 18 shared60.2%
- Bandhan Healthcare FundBandhan · 20 shared57.6%
- DSP Nifty Healthcare ETFDSP · 15 shared57.2%
- DSP Nifty Healthcare Index FundDSP · 15 shared57.2%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
- None this month.
Complete exits
- None this month.
Largest increases
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 12.03% | 1,073 Cr | 0.59 Cr | by Feb 2022 (55 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 7.30% | 651 Cr | 0.07 Cr | by Feb 2022 (55 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 6.34% | 565 Cr | 0.28 Cr | by Feb 2022 (55 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.18% | 551 Cr | 0.41 Cr | by Feb 2022 (55 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 5.60% | 499 Cr | 0.40 Cr | by Feb 2022 (55 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 5.02% | 448 Cr | 0.05 Cr | by Feb 2022 (55 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 4.50% | 401 Cr | 0.16 Cr | Apr 2023 (41 mo) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 4.03% | 359 Cr | 0.24 Cr | Dec 2024 (22 mo) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 3.71% | 331 Cr | 0.09 Cr | Apr 2022 (53 mo) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 3.20% | 285 Cr | 0.10 Cr | Aug 2022 (49 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.95% | 263 Cr | 0.14 Cr | Nov 2024 (23 mo) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 2.77% | 247 Cr | 0.27 Cr | Oct 2025 (12 mo) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 2.69% | 240 Cr | 0.17 Cr | by Feb 2022 (55 mo+) |
| Medplus Health Services Limited | Consumer Services | Small Cap | 2.60% | 232 Cr | 0.35 Cr | Nov 2022 (46 mo) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.60% | 232 Cr | 0.08 Cr | by Feb 2022 (55 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 2.39% | 213 Cr | 78,546 | by Feb 2022 (55 mo+) |
| Piramal Pharma Limited | Healthcare | Small Cap | 2.30% | 205 Cr | 0.99 Cr | Jun 2026 (4 mo) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 2.30% | 205 Cr | 0.38 Cr | by Feb 2022 (55 mo+) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 2.23% | 199 Cr | 0.10 Cr | Jun 2024 (28 mo) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 1.87% | 167 Cr | 0.03 Cr | by Feb 2022 (55 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 1.69% | 151 Cr | 0.09 Cr | by Feb 2022 (55 mo+) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 1.65% | 148 Cr | 0.08 Cr | by Feb 2022 (55 mo+) |
| Suraksha Diagnostic Limited | Not classified | Small Cap | 1.55% | 138 Cr | 0.39 Cr | Nov 2024 (23 mo) |
| Syngene International Limited | Healthcare | Small Cap | 1.43% | 128 Cr | 0.35 Cr | Oct 2022 (47 mo) |
| Emcure Pharmaceuticals Limited | Healthcare | Small Cap | 1.40% | 125 Cr | 0.06 Cr | Jul 2024 (27 mo) |
| Pfizer Limited | Healthcare | Small Cap | 1.38% | 123 Cr | 0.03 Cr | by Feb 2022 (55 mo+) |
| Akums Drugs and Pharmaceuticals Limited | Healthcare | Small Cap | 1.24% | 111 Cr | 0.14 Cr | Apr 2025 (18 mo) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 1.23% | 109 Cr | 0.13 Cr | Jul 2025 (15 mo) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 1.16% | 104 Cr | 0.13 Cr | by Feb 2022 (55 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 1.04% | 92.73 Cr | 0.25 Cr | Jan 2025 (21 mo) |
| Sanofi India Limited | Not classified | Small Cap | 1.03% | 91.79 Cr | 0.03 Cr | by Feb 2022 (55 mo+) |
| Sanofi Consumer Healthcare India Limited | Not classified | Small Cap | 0.91% | 81.25 Cr | 0.02 Cr | Jun 2024 (28 mo) |
| Molbio Diagnostics Limited | Not classified | — | 0.56% | 49.78 Cr | 0.04 Cr | Aug 2026 (2 mo) |
| Indoco Remedies Limited | Not classified | Small Cap | 0.49% | 43.96 Cr | 0.17 Cr | by Feb 2022 (55 mo+) |
| AstraZeneca Pharma India Limited | Not classified | Small Cap | 0.43% | 38.70 Cr | 62,568 | Dec 2023 (33 mo) |
| Concord Biotech Limited | Healthcare | Small Cap | 0.17% | 15.35 Cr | 0.01 Cr | Aug 2023 (37 mo) |
Half of its current holdings have been held for 49 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Sai Life Sciences Limited | Sep 2026 | ▼ Reducing | -0.02 Cr |
| Indoco Remedies Limited | Sep 2026 | ▼ Reducing | -0.02 Cr |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +420 |
| Biocon Limited | Aug 2026 | ▲ Increasing | +0.05 Cr |
| Molbio Diagnostics Limited | Aug 2026 | ▲ New position | +0.04 Cr |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▼ Reducing | -0.03 Cr |
| Cipla Limited | Aug 2026 | ▲ Increasing | +0.03 Cr |
| Anthem Biosciences Limited | Aug 2026 | ▲ Increasing | +0.02 Cr |
| Mankind Pharma Limited | Aug 2026 | ▲ Increasing | +0.02 Cr |
| Thyrocare Technologies Limited | Aug 2026 | ▼ Reducing | -0.02 Cr |
| Emcure Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -0.01 Cr |
| GlaxoSmithKline Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +0.01 Cr |
| Akums Drugs and Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -53,611 |
| Divi's Laboratories Limited | Aug 2026 | ▼ Reducing | -50,000 |
| Abbott India Limited | Aug 2026 | ▲ Increasing | +3,324 |
| Piramal Pharma Limited | Jul 2026 | ▲ Increasing | +0.44 Cr |
| Biocon Limited | Jul 2026 | ▲ Increasing | +0.05 Cr |
| Dr. Reddy's Laboratories Limited | Jul 2026 | ▼ Reducing | -0.04 Cr |
| Thyrocare Technologies Limited | Jul 2026 | ▼ Reducing | -0.04 Cr |
| Vijaya Diagnostic Centre Limited | Jul 2026 | ▼ Reducing | -0.02 Cr |
| Aurobindo Pharma Limited | Jul 2026 | ▼ Reducing | -0.01 Cr |
| Akums Drugs and Pharmaceuticals Limited | Jul 2026 | ▼ Reducing | -84,034 |
| Sanofi India Limited | Jul 2026 | ▲ Increasing | +70,000 |
| Mankind Pharma Limited | Jul 2026 | ▼ Reducing | -26,766 |
| Dr. Lal Path Labs Ltd. | Jul 2026 | ▼ Reducing | -17,646 |
| GlaxoSmithKline Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +15,615 |
| Abbott India Limited | Jul 2026 | ▲ Increasing | +463 |
| Piramal Pharma Limited | Jun 2026 | ▲ New position | +0.55 Cr |
| Aurobindo Pharma Limited | Jun 2026 | ▼ Reducing | -0.04 Cr |
| Vijaya Diagnostic Centre Limited | Jun 2026 | ▼ Reducing | -0.02 Cr |
| Fortis Healthcare Limited | Jun 2026 | ▲ Increasing | +0.02 Cr |
| Sun Pharmaceutical Industries Limited | Jun 2026 | ▼ Reducing | -0.02 Cr |
| Ajanta Pharma Limited | Jun 2026 | ▼ Reducing | -32,405 |
| Akums Drugs and Pharmaceuticals Limited | Jun 2026 | ▼ Reducing | -25,947 |
| Syngene International Limited | May 2026 | ▲ Increasing | +0.09 Cr |
| Vijaya Diagnostic Centre Limited | May 2026 | ▼ Reducing | -0.04 Cr |
| Mankind Pharma Limited | May 2026 | ▲ Increasing | +0.03 Cr |
| Cipla Limited | May 2026 | ▲ Increasing | +0.03 Cr |
| Aurobindo Pharma Limited | May 2026 | ▼ Reducing | -0.03 Cr |
| Dr. Lal Path Labs Ltd. | May 2026 | ▼ Reducing | -0.02 Cr |
| Divi's Laboratories Limited | May 2026 | ▼ Reducing | -0.01 Cr |
| Lupin Limited | May 2026 | ▼ Reducing | -0.01 Cr |
| Medplus Health Services Limited | May 2026 | ▼ Reducing | -82,048 |
| Thyrocare Technologies Limited | May 2026 | ▼ Reducing | -33,271 |
| Abbott India Limited | May 2026 | ▲ Increasing | +152 |
| J.B. Chemicals & Pharmaceuticals Lt | Apr 2026 | ▼ Complete exit | -0.08 Cr |
| Dr. Reddy's Laboratories Limited | Apr 2026 | ▲ Increasing | +0.07 Cr |
| Syngene International Limited | Apr 2026 | ▲ Increasing | +0.07 Cr |
| Vijaya Diagnostic Centre Limited | Apr 2026 | ▼ Reducing | -0.04 Cr |
| Sun Pharmaceutical Industries Limited | Apr 2026 | ▲ Increasing | +0.01 Cr |
| Thyrocare Technologies Limited | Apr 2026 | ▲ Increasing | +8,060 |
| Biocon Limited | Mar 2026 | ▼ Reducing | -0.07 Cr |
| Max Healthcare Institute Limited | Feb 2026 | ▲ Increasing | +0.14 Cr |
| Mankind Pharma Limited | Feb 2026 | ▲ Increasing | +0.02 Cr |
| J.B. Chemicals & Pharmaceuticals Lt | Feb 2026 | ▼ Reducing | -0.02 Cr |
| Dr. Reddy's Laboratories Limited | Feb 2026 | ▼ Reducing | -0.02 Cr |
| Apollo Hospitals Enterprise Limited | Feb 2026 | ▼ Reducing | -0.01 Cr |
| Narayana Hrudayalaya Ltd. | Feb 2026 | ▼ Reducing | -0.01 Cr |
| Ajanta Pharma Limited | Feb 2026 | ▼ Reducing | -13,000 |
| Syngene International Limited | Jan 2026 | ▲ Increasing | +0.05 Cr |
| Orchid Pharma Limited | Jan 2026 | ▼ Complete exit | -0.05 Cr |
| Max Healthcare Institute Limited | Jan 2026 | ▲ Increasing | +0.04 Cr |
| IPCA Laboratories Limited | Jan 2026 | ▲ Increasing | +0.02 Cr |
| Mankind Pharma Limited | Jan 2026 | ▲ Increasing | +0.01 Cr |
| Biocon Limited | Dec 2025 | ▼ Reducing | -0.20 Cr |
| Gland Pharma Limited | Dec 2025 | ▼ Reducing | -0.05 Cr |
| Lupin Limited | Dec 2025 | ▼ Reducing | -0.02 Cr |
| Syngene International Limited | Dec 2025 | ▲ Increasing | +0.01 Cr |
| IPCA Laboratories Limited | Dec 2025 | ▲ Increasing | +70,000 |
| Divi's Laboratories Limited | Dec 2025 | ▼ Reducing | -50,000 |
| Emcure Pharmaceuticals Limited | Dec 2025 | ▲ Increasing | +6,078 |
| Abbott India Limited | Dec 2025 | ▲ Increasing | +5,510 |
| Biocon Limited | Nov 2025 | ▼ Reducing | -0.05 Cr |
| Emcure Pharmaceuticals Limited | Nov 2025 | ▲ Increasing | +0.03 Cr |
| Thyrocare Technologies Limited | Nov 2025 | ▼ Reducing | -0.03 Cr |
| IPCA Laboratories Limited | Nov 2025 | ▲ Increasing | +0.01 Cr |
| Divi's Laboratories Limited | Nov 2025 | ▼ Reducing | -99,277 |
| Orchid Pharma Limited | Nov 2025 | ▼ Reducing | -35,166 |
| Max Healthcare Institute Limited | Oct 2025 | ▲ New position | +0.09 Cr |
| Torrent Pharmaceuticals Limited | Oct 2025 | ▼ Complete exit | -0.03 Cr |
| Zydus Lifesciences Limited | Oct 2025 | ▼ Complete exit | -0.02 Cr |
| IPCA Laboratories Limited | Oct 2025 | ▲ Increasing | +0.02 Cr |
| Narayana Hrudayalaya Ltd. | Oct 2025 | ▼ Reducing | -0.01 Cr |
| Thyrocare Technologies Limited | Oct 2025 | ▼ Reducing | -24,136 |
| Zydus Lifesciences Limited | Sep 2025 | ▼ Reducing | -0.18 Cr |
| Biocon Limited | Sep 2025 | ▲ Increasing | +0.05 Cr |
| Lupin Limited | Sep 2025 | ▲ Increasing | +0.04 Cr |
| Cipla Limited | Sep 2025 | ▲ Increasing | +0.03 Cr |
| Thyrocare Technologies Limited | Sep 2025 | ▼ Reducing | -0.02 Cr |
| IPCA Laboratories Limited | Sep 2025 | ▲ Increasing | +34,608 |
| Biocon Limited | Aug 2025 | ▲ Increasing | +0.03 Cr |
| Dr. Lal Path Labs Ltd. | Aug 2025 | ▼ Reducing | -50,000 |
| Anthem Biosciences Limited | Jul 2025 | ▲ New position | +0.11 Cr |
| Suraksha Diagnostic Limited | Jul 2025 | ▲ Increasing | +0.06 Cr |
| Akums Drugs and Pharmaceuticals Limited | Jul 2025 | ▲ Increasing | +0.06 Cr |
| Dr. Reddy's Laboratories Limited | Jul 2025 | ▲ Increasing | +0.05 Cr |
| Narayana Hrudayalaya Ltd. | Jul 2025 | ▼ Reducing | -0.04 Cr |
| Gland Pharma Limited | Jul 2025 | ▼ Reducing | -0.02 Cr |
| Divi's Laboratories Limited | Jul 2025 | ▼ Reducing | -70,000 |
| Dr. Lal Path Labs Ltd. | Jul 2025 | ▼ Reducing | -50,000 |
Changes compare consecutive month-end disclosures for this portfolio only.